欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:
程序性死亡配体1基因遗传变异对术后结直肠癌患者接受5-FU为基础辅助化疗预后的影响
白 艳,郑晓永,杨雅阁,方立峰
Influence of programmed death-ligand 1 genetic variation on the clinical outcomes of postoperative CRC patients received 5-FU based adjuvant chemotherapy
BAI Yan, ZHENG Xiaoyong, YANG Yage, FANG Lifeng
中国临床药理学与治疗学 . 2019, (2): 180 -187 .  DOI: 10.12092/j.issn.1009-2501.2019.02.010